2024-05-10T12:45:54-05:00 2023-12-31 461171913 S D MAYER & ASSOCIATES LLP 411 BOREL AVENUE SUITE 512 SAN MATEO CA 94402 990 2023-01-01 300012730 DIABETES TECHNOLOGY SOCIETY DIAB 6506927100 845 MALCOLM ROAD 5 BURLINGAME CA 94010 DAVID C KLONOFF DR 6506927100 2024-05-10 1 DAVID KLONOFF 999009999 0 MARIANNE KRISTOFFERSON P00024506 6505745000 2024-05-08 2 AAL1 IAL1 2023 2023-04-26 12:10:37Z DAVID C KLONOFF 845 MALCOLM ROAD BURLINGAME CA 94010 1379124 0 X WWW.DIABETESTECHNOLOGY.ORG X 2001 CA TO FACILITATE RESEARCH INTO THE TREATMENT,MONITORING, DIAGNOSIS AND PREVENTION OF DIABETES. 4 3 7 6 0 0 738153 967906 418745 371507 7048 38517 0 1194 1163946 1379124 0 21800 0 0 833763 624355 0 0 0 433785 457245 1267548 1103400 -103602 275724 1334588 1611702 11118 12508 1323470 1599194 X TO FACILITATE RESEARCH INTO THE TREATMENT, MONITORING, DIAGNOSIS AND PREVENTION OF DIABETES. 0 0 957608 21800 371507 TO FURTHER EDUCATION PROFESSIONALS AND THE PUBLIC ON THE TREATMENT, MONITORING, DIAGNOSIS AND PREVENTION OF DIABETES. THIS WAS ACHIEVED BY HOLDING SEVEN (7) EDUCATIONAL VIRTUAL CONFERENCES IN 2023, MAINTAINING AN INFORMATIONAL WEBSITE, LAUNCHING AN ONGOING PODCAST WITH LEADERS IN THE DIABETES TECHNOLOGY FIELD, LAUNCHING A SPANISH/ENGLISH DUAL-LANGUAGE INFORMATIONAL WEBSITE AND PUBLISHING 1,739 PAGES OF TECHNICAL ARTICLES ABOUT DIABETES AND DIABETES TECHNOLOGY. CONFERENCES HELD IN 2023, THE NUMBER OF ATTENDEES AND OTHER PROJECTS ARE AS FOLLOWS:1. VIRTUAL HOSPITAL CONTINUOUS GLUCOSE MONITOR MEETING (HDM 2023) APRIL 14-15, 2023; 207 ATTENDEES.2. LIPOHYPERTROPHY AND INSULIN. AN OLD DOG THAT NEEDS NEW TRICKS(LIPOHYPERTROPHY 2023) APRIL 26, 2023; 254 ATTENDEES.3. THE INTEGRATION OF CONNECTED DEVICE DATA INTO THE ELECTRONIC HEALTH RECORD STANDARD (ICODE-2 2023) MAY 31, 2023; 70 ATTENDEES.4. BIOMARKERS FOR DIAGNOSIS OF HEART FAILURES IN DIABETES (BIOMARKERS INITIATIVE 2023) SEPTEMBER 20, 2023; 213 ATTENDEES.5. STANDARDIZATION OF CGM PERFORMANCE EVALUATIONS-DEVELOPMENTS FROM THE IFCC WORKING GROUP ON CGM (CGM PERFORMANCE STANDARDS 2023)NOVEMBER 1, 2023; 175 ATTENDEES.6. VIRTUAL DIABETES TECHNOLOGY MEETING PRODUCT THEATRE (DTM PRODUCT THEATRE 2023); NOVEMBER 1, 2023; 141 ATTENDEES.7. VIRTUAL DIABETES TECHNOLOGY MEETING (2023 DTM) NOVEMBER 2-4, 2023; 307 ATTENDEES.OTHER PROJECTS:DIABETES TECHNOLOGY REPORT(DTS PODCAST)JUNE 22, 2023DTS LAUNCHED AN ONGOING PODCAST WITH LEADERS IN THE DIABETES TECHNOLOGY FIELD.SALUDDIABETES.ORG(SALUD 2023)AUGUST 8, 2023DTS LAUNCHED A SPANISH/ENGLISH DUAL-LANGUAGE WEBSITE THAT SUMMARIZES RECENT PUBLICATIONS IN DIABETES AND HEALTH FOR THE LAYPERSON.JDST (JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY)PUBLISHED 1,739 PAGES OF TECHNICAL ARTICLES ABOUT DIABETES AND DIABETES TECHNOLOGY- THE LAUNCH OF THE ICODE-2 STANDARD PROJECT: INTEGRATION OF CONNECTED DIABETES DEVICE DATA INTO THE ELECTRONIC HEALTH RECORD - OCTOBER 18, 2023- NIH FIFTH ARTIFICIAL PANCREAS WORKSHOP 2023: MEETING REPORT: THE FIFTH ARTIFICIAL PANCREAS WORKSHOP: ENABLING FULLY AUTOMATION, ACCESS AND ADOPTION - OCTOBER 9, 2023- A CONSENSUS STATEMENT FOR CONTINUOUS GLUCOSE MONITORING METRICS FOR INPATIENT CLINICAL TRIALS - NOVEMBER 17, 2023- USE OF CONTINUOUS GLUCOSE MONITORS IN THE HOSPITAL: THE DIABETES TECHNOLOGY SOCIETY HOSPITAL MEETING REPORT 2023 - SEPTEMBER 17, 2023- LIPOHYPERTROPHY AND INSULIN: AN UPDATE FROM THE DIABETES TECHNOLOGY SOCIETY - NOVEMBER 17, 2023- CONTINUOUS SUBCUTANEOUS INFUSION VERSUS MULTIPLE DAILY INJECTIONS OF INSULIN FOR PREGESTATIONAL DIABETES IN PREGNANCY: A SYSTEMATIC REVIEW AND META-ANALYSIS - SEPTEMBER 17, 2023- TWENTY-FIRST CENTURY MANAGEMENT OF DIABETES WITH SHARED TELEMEDICINE APPOINTMENTS - JULY 20, 2023- PEOPLE WITH DIABETES USING INSULIN FLYING ACROSS MULTIPLE TIME ZONES: LIMITATIONS AND OPPORTUNITIES FOR DIABETES TECHNOLOGIES - OCTOBER 29, 2023- DIABETES RESEARCH AND RESOURCE SHARING DURING THE COVID-19 PANDEMIC: A SYSTEMATIC REVIEW AND EXPERIENCE FROM AN ACADEMIC/NON-PROFIT RESOURCE WEBSITE - SEPTEMBER 17, 2023- THE NEED FOR DATA STANDARDS AND IMPLEMENTATION POLICIES TO INTEGRATE INSULIN DELIVERY DATA INTO THE ELECTRONIC HEALTH RECORD - SEPTEMBER 17, 2023- BIOMARKERS FOR THE DIAGNOSIS OF HEART FAILURE IN PEOPLE WITH DIABETES: A CONSENSUS REPORT FROM DIABETES TECHNOLOGY SOCIETY - JULY-AUGUST 2023- LIPOHYPERTROPHY AND INSULIN: AN OLD DOG THAT NEEDS NEW TRICKS - AUGUST 29, 2023- REAL-WORLD EVIDENCE SUPPORTS HIGHER PREVALENCE OF HEART FAILURE AMONG PERSONS WITH TYPE 1 AND TYPE 2 DIABETES COMPARED WITH THE GENERAL POPULATION - MAY 17, 2023- USING CHATGPT TO PREDICT THE FUTURE OF DIABETES TECHNOLOGY - MAY 17, 2023- UPDATE ON MEASURING KETONES - FEBRUARY 16, 2023- DIABETES TECHNOLOGY MEETING 2022 - JULY 17, 2023- REGARDING "DETECTION OF HYPOGLYCEMIA AND HYPERGLYCEMIA USING NONINVASIVE WEARABLE SENSORS: ECG AND ACCELEROMETRY" - NOVEMBER 17, 2023- USE OF CONTINUOUS GLUCOSE MONITORS UPON HOSPITAL DISCHARGE OF PEOPLE WITH DIABETES: PROMISE, BARRIERS, AND OPPORTUNITY - OCTOBER 2, 2023 957608 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 16 0 1 7 1 0 0 0 0 0 0 0 0 0 0 0 0 X 4 3 0 0 0 0 0 0 0 1 1 0 0 1 0 0 0 1 1 0 CA X JANIE CHUCK 6506927100 845 MALCOLM ROAD SUITE 5 BURLINGAME CA 94010 DR DAVID KLONOFF MD PRESIDENT 40.00 X X 297813 0 2234 HENRY WYKOWSKI DIRECTOR 1.00 X 0 0 0 AVERY DIAMOND DIRECTOR 1.00 X 0 0 0 DR GERALD R SYDORAK MD DIRECTOR 1.00 X 0 0 0 297813 0 2234 1 0 1 0 DANIEL G SHILSTONE 1744 BALSA AVE SAN JOSE CA 95124 OUTSIDE SERVICES 109750 1 967906 967906 COPYRIGHT INCOME 513120 274882 274882 CONFERENCE INCOME 541900 96625 96625 371507 38517 38517 REIMBURSED EXPENSES 900099 1194 1194 1194 1379124 371507 0 39711 X 20000 20000 1800 1800 297813 297813 273474 273474 3577 3577 12198 12198 37293 37293 7756 7756 5180 5180 255935 201176 54759 18080 3890 14190 24255 24255 35286 34990 296 2767 2767 7062 7062 CONFERENCE FEES 77698 77698 TELEPHONE 6876 6876 MERCHANT FEES 5205 5205 DUES AND SUBSCRIPTIONS 4214 719 3495 6931 3550 3381 1103400 957608 145792 0 1330379 1610260 0 0 130954 130573 1488 381 2721 1061 1334588 1611702 11118 12508 11118 12508 X 1323470 1599194 1323470 1599194 1334588 1611702 275724 0 X 0 0 0 X 535500 575000 790036 738153 967906 3606595 535500 575000 790036 738153 967906 3606595 3606595 1682 1546 142 7048 38517 48935 30725 20100 1194 52019 3707549 2000128 0.97280 0.97440 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 130954 130573 381 381 0 ANN & ROBERT H LURIE CHILDREN'S HOSPITAL OF CHICAGO FOUNDATION 225 E CHICAGO AVENUE CHICAGO IL 60611 363357006 501(C)(3) 20000 0 DIABETES DIGITAL HEALTH & INNOVATIONS AWARD 1 0 1 X X X 0 0 0 0 0 0 0 0 0 DR DAVID KLONOFF MD PRESIDENT 297813 0 0 0 0 0 2234 0 0 0 300047 0 0 0 PART I, LINE 1B EXPENSES ARE APPROVED BY THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11B MANAGEMENT REVIEWS FORM 990 FOR FUTURE MANAGEMENT DECISION MAKING. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD REVIEWS AND APPROVES COMPENSATION FOR OFFICERS AND KEY EMPLOYEES USING COMPARABILITY DATA FROM COMPENSATION SURVEY OR STUDY, AND FORM 990 OF OTHER ORGANIZATIONS. FORM 990, PART VI, SECTION C, LINE 19 DOCUMENTS ARE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G OUTSIDE SERVICES: PROGRAM SERVICE EXPENSES 121,750. MANAGEMENT AND GENERAL EXPENSES 53,540. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 175,290. PAYROLL SERVICE FEES: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 1,219. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,219. HONORARIUM: PROGRAM SERVICE EXPENSES 8,100. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 8,100. CONSULTING: PROGRAM SERVICE EXPENSES 13,316. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 13,316. GRANT WRITING SERVICES: PROGRAM SERVICE EXPENSES 560. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 560. EDITORIAL SERVICES: PROGRAM SERVICE EXPENSES 40,000. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 40,000. CERTIFICATION FEES: PROGRAM SERVICE EXPENSES 17,450. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 17,450.